Vegas63 wrote:Some posters ask frequently " how does cannabis going to a schedule 3 effect Tilray " ??
First lets look at what schedule 3 drugs in the United States are ;
Schedule III ; Drugs with low to moderate potential for abuse and / or addiction .,..
Some examples of Schedule 3 drugs are ;
- Products containing less than 90 milligrams of codeine per dosage unit ( Tylenol with codeiine )
- Ketamine
- Anabolic steroids
- Testosterone
these are only a few samples of schedule 3 drugs in the United States ,, you can look it up on the internet to see more if you want ,,,
Once cannabis ( marijuana ) joins the list of schedule 3 drugs that's it ... it is now a schedule 3
drug according to the law ..
Some states have different lists of schedule 3 drugs but Cannabis will be on it ,,.,
On January 5 , 2024 , the Food and Drug Administration ( FDA ) authorized the state of Florida
to import prescription drugs from Canada ..,. to take advantage of LOWER costs Canada is producing and selling ,,.,.
the drugs Florida will want to import include those that treat HIV/AIDS , mental health conditions , prostate cancer and othe cancers ,,, you can look at the whole list if you go on the internet ,,,
other States want in on the importing of Canada's prescription drugs including Cailforna
as Florida has stated it would save them hundreds of millions by importing Prescription drugs from Canada ..,.
I am not a corperate lawyer but I am sure Tilray has coperate lawyers that have looked into
what prescription drugs Florida will be importing that are schedule 3 drugs ,,.,
as mentioned if the FDA has approved any schedule 3 drugs to be imported to Florida from Canada a Precedent has been set ... meaning Cannibis / Marijuana is just another schedule 3 drug if Florida wants to import they legally would be able to ...
That is actually an interesting perspective, you may be on to something there! The medical side of the market may benefit Canadian LP's if they can tap into it. The assumtion though is that big pharma will inflate the prices in the US, so that is dependent on pharma entry into the sector. Wouldn't that be ironic if pharma entered through Tilray lpl. I'm sure that will be clarified in legislation once rescheduled. Thanks for that perspective Vegas!